OR WAIT null SECS
AB SCIEX (Framingham, Massachusetts, USA) has announced the AB SCIEX Academic Partnership Programme to increase the number of scientists who benefit from the company?s assistance and resources for advancing research in proteomics, metabolomics and lipidomics.
AB SCIEX (Framingham, Massachusetts, USA) has announced the AB SCIEX Academic Partnership Programme to increase the number of scientists who benefit from the company’s assistance and resources for advancing research in proteomics, metabolomics and lipidomics. The company are linking with academic researchers to overcome the barriers put up by hard-to-obtain technologies that prevent advancements and breakthroughs in medicine and biology.
The programme hopes to simplify the grant-writing process for researchers and provide access to technical expertise and support in mass spectrometry and chromatography. The company will also provide sponsorships for promising research that shows exemplary use of LC–MS–MS.
One researcher who has benefitted from a collaborative relationship with AB SCIEX is Anne-Claude Gingras of the Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada. She commented, “I think that partnering with an industry leader such as AB SCIEX is invaluable for an academic researcher. Cooperation between academia and industry has been important in significant scientific advancements, and AB SCIEX has quite a bit of credibility from being part of some major breakthroughs.”
Ron Bonner, principal scientist, AB SCIEX, said, “We believe that the next great breakthroughs in biomedical research will come from network biology, so we are partnering with academic researchers around the world to help support their important research.”